ASINEX is a cutting edge company
specialising in highly innovative medicinal chemistry that is able to
address unmet medical needs. With over 17 years' experience in the
field, we have been constantly developing our products and services in
order to provide the pharmaceutical and biotech research communities
with innovative design resulting in truly novel compounds.
Our particular strength is the ability to
conceive new design concepts for the development of novel compounds for
previously intractable drug targets. We exploit these design concepts
with state-of-the-art expertise in computational and medicinal chemistry
to generate unique compounds.
The BioDesign libraries are one of ASINEX's
latest innovations. At the heart of the BioDesign concept is the
incorporation of saturated, spiro and oxy features, along with
chirality, 3D geometry and good experimental solubility. We have been
focusing on compounds which are highly privileged and at the same time
under-represented in commercial sources. ASINEX's niche is the design of
truly useful, novel compounds that require a high degree of synthetic
expertise and design know-how.
Our most recent novel design concept is the
BioMimetic Library. Natural product structures, along with the
mechanisms of their biosynthesis, have been an invaluable source of
inspiration. Skeletally and functionally diverse natural product
derivatives have been designed in order to further advance ASINEX's
portfolio of BioDesign compound arrays by exploiting a biomimetic
ASINEX has a reputation for efficient
customer service and reliable supply. We take pride in the purity and
stability of the compounds, order turnaround time, rate of resupply and
other follow-up services.
ASINEX is a leader in the provision of
exclusive library synthesis, lead optimization and multi-step custom
synthesis. In addition to chemistry we also provide in-silico driven
lead generation, bioscreening and compound management services.
More detailed descriptions of our libraries
can be found on the website. We would be delighted to discuss any
enquiries you may have about our existing compounds, or thoughts
concerning future library design that may be able to address your unmet